Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
LEARN WHAT WATERSLATEST INNOVATIVE MS TECHNOLOGIES
CAN DO FOR YOUWaters is proud to invite you to an open Waters Users Meeting to learn about our latest innovative technologies introduced at ASMS 2010, including the new Xevo™ high performance Benchtop MS Instruments based upon the Engineered Simplicity™ design approach with a unique workflow software solution for each application field.
The agenda will run on four parallel tracks focusing on: Biopharmaceutical, Clinical, Food & Environmental, and Pharmaceuticals.
This event will explore how innovative technologies and applications can increase your productivity and efficiency, including: • Stepwave™ technology for ultra high sensitivity MRM, • meeting the sensitivity challenges of dry blood spot analysis, • accurate mass for the qualitative and quantitative approach, • screening for residues; one UPLC®-MS dataset for the targeted and untargeted approach.
This meeting will give you the opportunity to talk to your colleagues and other experts, sharing opinions, experiences and ideas.
Feel free to forward this invitation to interested colleagues. Seats are limited though, so please register at www.waters.com/msdays now! We look forward to meeting you at one of our venues.
Mike van OosterhoutStrategic Markets ManagerWaters Corporation
© 2010 Waters Corporation. Waters, Xevo, Engineered Simplicity, Stepwave, UPLC and The Science of What’s Possible are trademarks of Waters Corporation.
UT RECHT – MONDAY, OCTOBER 11BRUSSELS – TUESDAY, OCTOBER 12FRANKFURT – THURSDAY, OCTOBER 14BASEL – FRIDAY, OCTOBER 15
BASEL, SWITZERLANDFRIDAY OCTOBER 15, 2010
09:00 Registration
09:30 Stepwave™: Ultra High Sensitivity MRM on the Xevo™ TQ-S David Little, Director - MS Product Management, Waters Corporation
10:00 Addressing the Sensitivity Challenges of Dry Blood Spot Analysis Jing Lin, Pharmaceutical Marketing Team Manager, Europe & India, Waters Corporation
10:30 Coffee Break
10:45 Accurate Mass for the Quantitative and Qualitative Approach enabled by Quantof™ Technology on the Xevo G2 QTof™ Mark McDowall, Strategic Development Manager, Waters Corporation
11:15 Residue Screening and Unknown Compound Discovery using MSE enabled UPLC®/QTof Timothy Jenkins, Business Operations Manager, Waters Corporation
11:45 Additional Innovations in Mass Spectrometry… and Related Techniques 2010 Mark McDowall, Strategic Development Manager, Waters Corporation
12:15 Lunch
13:30 Parallel Tracks
14:20 Coffee Break
14:45 Parallel Tracks
16:00 Closing Drinks
This event is FREE to attend. Accommodation and transportation to/from the hotel is the responsibility of the participant.
* See details on backpage.
© 2010 Waters Corporation. Waters, Stepwave, Xevo, QuanTof, QTof, UPLC and The Science of What’s Possible are trademarks of Waters Corporation.
BIOPHARMACEUT ICAL CLINICAL FOOD & ENV IRONMENTAL PHARMACEUT ICAL
Biopharmaceutical Analysis and the Waters Solutions
Alexander Muck Biopharmaceutical Specialist,
Central Europe, Waters Corporation
13:30 13:30 13:30 13:30Semi-Automated High Throughput Analysis Approach using the Tecan
EVO 100 and UPLC/MS/MS for 25-OH Vitamin D and Plasma Free
Metanephrines Peter Batjoens
Clinical Specialist, Waters Corporation
A Complementary Approach for the Analysis
of Pesticide Residues Dr. Andreas Tei
Waters Corporation
Metabolite Profiling using the GCT™ and the SYNAPT® G2
Endre Laczko Functional Genomic Cente,
UZH / ETHZ, Zürich
A Small Molecule Sample Profiling Strategy
using UPLC/oa-TOF MSE/Ion Mobility MS as the Analytical Tool
Richard Lock Manager HRMS System Support
Group, Waters Corporation
Combined Ion Mobility Mass Spectrometry for Metabolite
Characterization Frederic Lozach
DMP Biotransformation, Novartis Pharma AG, Basel
Development of a Lipidomic Platform Based on a Hybrid Quadrupole Time-
of-Flight (QTof) Ion-Mobility Mass Spectrometer for both Targeted and
non-Targeted Analysis Richard Lock
Manager HRMS System Support Group, Waters Corporation
False Positive and False Negative Results Dr. Anton Kaufmann
Kantonales Labor Zürich
Sensitive Direct Injection Analysis of Environmental Water Samples
with UPLC® Xevo™ TQ-S David Little
Director - MS Product Management, Waters Corporation
Novel Applications of APGC Technology in Food and Environmental Analysis
Timothy Jenkins Business Operations Manager,
Waters Corporation
Screening for Toxicologically Relevant Compounds – Toxicology
Screening using UPLC/MS/MS Dr. Markus Heck
Application Specialist, Waters AG Baden
Systematic Toxicological Screening using High Resolution Q-Tof
Technology and POSI±IVE Software Peter Batjoens
Clinical Specialist, Waters Corporation
Experiences with BiopharmaLynx™ in the Biopharma Industry Dr. Jörg Hörnschemeyer, Hoffmann-La Roche AG
HCP Analysis and HDX Applications in Biopharma
Scott Berger, Marketing Development Manager,
Waters Corporation
Characterisation of Glycoproteins by MS Methods
Dr. Luc-Alain Savoy M-Scan SA
ETD and HDMSE… Enabling Technologies for Biopharma
Mark McDowall Strategic Development Manager,
Waters Corporation
Peptides Quantification: One Step Beyond with Xevo TQ-S
Stéphane Canarelli Application Specialist,
Waters Corporation
The UPLC/MSE Workflow for Qualitative and Quantitative
Metabolite Identification Jing Lin
Pharmaceutical Marketing Team Manager,
Waters Corporation
© 2010 Waters Corporation. Waters, BiopharmaLynx, UPLC, Xevo, GCT, SYNAPT and The Science of What’s Possible are trademarks of Waters Corporation.Other trademarks are property of their respective owners.
WATERS MS TECHNOLOGY DAYS PARALLEL T RACKSBASEL, SWITZERLAND — FRIDAY OCTOBER 15, 2010
13:55 14:00 14:00 13:55
14:20 14:30 14:25 14:25
14:45 14:50 14:55
15:15 15:20
15:45